Auxilium Pharmaceuticals, a biopharmaceutical company, has obtained an approval from the US Food and Drug Administration (FDA) for Xiaflex (collagenase clostridium histolyticum) for the treatment of Peyronie's disease. The company claims ...
Tags: Peyronie's Disease Drug, Medicine
Gilead Sciences has announced that the US Food and Drug Administration (FDA) has approved Sovaldi (sofosbuvir) 400mg tablets, a once-daily oral nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (CHC) infection ...
Tags: Gilead Sciences, Chronic Hepatitis
Dietary supplements are dominating the shelves of pharmacy retailers, with brands vying for the attention of health-conscious consumers. In fact, industry experts report that approximately 50% of American adults take dietary supplements. ...
Tags: Light Industry, Daily Use
Oculus Innovative Sciences has obtained 510(k) approval from the US Food and Drug Administration (FDA) for its new Microcyn scar management HydroGel, intended to manage old and new hypertrophic and keloid scarring resulting from burns, ...
China-based Wuxi Glory Plastics has extended its product line with the launch of a new collection of tablet bottles. Available in different shapes and sizes, the new bottles are said to be made from durable materials and manufactured in ...
Tags: Plastics, Tablet Bottles
Novian Health, the developer of Novilase breast therapy, has announced the issuance of a new US patent covering the interstitial laser therapy in combination with interstitial brachytherapy treatment. Novian Health has developed the ...
Tags: Novian Health, Breast Cancer
From 2005-11, ecstasy-related U.S. hospital emergency department visits rose 128 percent for those age 21 and younger, mental health officials said. A report from the Substance Abuse and Mental Health Services Administration, part of the ...
British-Dutch multinational company Unilever is looking to cut its product portfolio by 30% by the end of 2014, in a move to become more efficient and reverse its global slowdown. The company also said that it is set to eliminate 2,000 ...
Tags: Unilever, higher-growth markets
Sanofi has released results of a 24-week Phase IIIb clinical trial showing that Lyxumia (lixisenatide) met the primary endpoint of non-inferiority in blood sugar lowering (HbA1c) when administered to patients either before breakfast or the ...
Tags: Diabetes Drug, Medicine
Teva Pharmaceutical has licensed rights to commercialize glatiramer acetate to Takeda Pharmaceutical in Japan as part of their agreement signed earlier in 2013. Currently both the firms are working on additional agreements for ...
Tags: Teva Licenses, Medicine
Roche and Molecular Partners have entered into a research collaboration and licensing agreement to discover, develop and commercialize several proprietary therapeutics incorporating Molecular' DARPin biologics conjugated to toxic agents ...
Tags: Roche, Molecular Partners
Wolters Kluwer Health, a provider of information for healthcare professionals and students, has announced that its Medi-Span Controlled Substances Drug File has been selected by Health Market Science (HMS) for integration with its ...
Tags: Health Market, Medicine
Ventana Medical Systems, a member of the Roche Group, has obtained the US Food and Drug Administration’s (FDA) 510(k) approval for its Companion Algorithm ER (SP1) image analysis algorithm used with the Ventana iScan Coreo scanner ...
Tags: Breast Cancer, Analysis Algorithm
The pharmaceutical industry demands for UPW for injection (WFI) and UPW for cleaning process equipment and other uses will result in purchases close to $500 million in 2017 up from $425 million this year. This is the latest forecast in the ...
Tags: consumables, health
Linkam Scientific Instruments report on the use of their stages for supramolecular polymer research at the Eindhoven University of Technology in the Netherlands. As part of the Supramolecular polymer chemistry group at the Eindhoven ...
Tags: supramolecular, Linkam